China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

Sequencers generate vast amounts of data in the sequencing process to better understand human health and ... Element Biosciences, Genewiz, Illumina, Inc., Macrogen, MGI, OncoDNA, Oxford Nanopore, ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...

Regeneron and Illumina have joined a major investment ... drug discovery and transform patient care." After the initial sequencing, the biospecimens will be stored to support future multi-omics ...